Joe has a uniquely diverse scientific background and advanced degrees in biology, chemistry and computer science. He has more than a decade of experience in drug discovery and development, in both academic and industrial settings. Formerly a research fellow at a Fortune 500 pharmaceutical company, Joe directly contributed to multiple inventions of novel clinical candidates and played key roles in advancing three preclinical programs into clinical stages. The therapeutic areas that he has worked on include oncology, inflammation, cardiovascular, neuroscience and infectious diseases.
He is well versed in medicinal chemistry, organic chemistry, nanomaterials, molecular biology, biochemistry, cell biology, immunology, neurology and pharmacology. He also has extensive experience in pharmaceuticals, therapeutic protein engineering and production, antibody and vaccine development and medical diagnostics.
In addition, he has experience with machine learning, artificial intelligence, data mining, cloud computing, digital image analysis and processing, database management system, network security and protocols, cyber security and other information technologies.
Before Fox Rothschild
Prior to joining Fox, Joe was a research fellow at a leading global pharmaceutical company, where he managed teams for seven drug discovery programs. He completed his postdoctoral research at Princeton University.
Honors & Awards
- 2015 Employee of the Year, Vitae Pharmaceuticals (acquired by Allergan plc)
- Best Presentation Award, Princeton University Retreat (2008)